Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArbuthnot Regulatory News (ARBB)

Share Price Information for Arbuthnot (ARBB)

Share Price is delayed by 15 minutes
Get Live Data
840.00    -10.00 (-1.18%)
Bid:
805.00
Ask:
840.00
Spread: 35.00 (4.348%)
Market Cap: £137.09m
ARBB Live PriceLast checked at - London Stock Exchange

Intraday Arbuthnot Share Chart

Form 8.3 - Camper & Nicholsons

17 Mar 2011 17:30

RNS Number : 1507D
Arbuthnot Banking Group PLC
17 March 2011
 



FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OF MORE

Rules 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

ARBUTHNOT BANKING GROUP PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

 

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

CAMPER & NICHOLSONS MARINA INVESTMENTS LIMITED

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree

(e) Date position held/dealing undertaken:

17 March 2011

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary Shares of no par value

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,600,000

2.66

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

1,600,000

2.66

 

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description e.g. CFD

Nature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product descriptione.g.call option

Writing, purchasing, selling, varying, etc

Number of securities to which option relates

Exercise price per unit

Typee.g American, European, etc

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product descriptione.g.call option

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealinge.g.subscription, conversion

Details

Price per unit )if applicable)

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any patry to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

Date of disclosure:

17 March 2011

Contact name:

James Cobb

Telephone number:

020 7012 2000

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETDMGMFZNLGMZM
Date   Source Headline
1st Jun 20267:00 amRNSAdmission of Non-Voting Shares to Trading on AIM
20th May 20267:00 amRNSAppointment of New Non-Executive Director
19th May 20263:45 pmRNSResult of AGM
19th May 20262:34 pmRNSAnnual General Meeting 2026 & Trading Update
26th Mar 20263:37 pmRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSAudited Final Results for the year to 31/12/2025
11th Mar 20262:34 pmRNSHolding(s) in Company
19th Feb 20267:00 amRNSPre Close Trading Update
23rd Oct 20257:00 amRNSThird Quarter 2025 Trading Update
22nd Jul 20257:00 amRNSUnaudited results for the six months to 30/06/2025
8th Jul 20257:00 amRNSAppointment of independent non-executive director
21st May 20253:40 pmRNSResult of AGM
21st May 20252:19 pmRNS2025 AGM Trading Update
27th Mar 20257:00 amRNSAudited Final Results for the year ended 31/12/24
20th Feb 20257:00 amRNSPre-Close Trading Update
25th Nov 20242:31 pmRNSDirector/PDMR Shareholding
17th Oct 20247:00 amRNSThird Quarter 2024 Trading Update
12th Aug 20248:59 amRNSChange of Registered Office
23rd Jul 20247:00 amRNSUnaudited results for the six months to 30/06/2024
2nd Jul 20249:41 amRNSAppointment of Independent Non-Executive Director
5th Jun 20243:35 pmRNSHolding(s) in Company
4th Jun 202412:02 pmRNSCompletion of Tier 2 Reg. Cap. Facility Renewal
30th May 20247:00 amRNSNotification of Special and Interim Dividends
22nd May 20243:41 pmRNSResult of AGM
22nd May 20247:00 amRNSAnnual General Meeting 2024 Trading Update
22nd Apr 20243:49 pmEQSQ&A on Arbuthnot Banking Group (ARBB) | 2023 results, strategic choices paying dividends
8th Apr 20243:50 pmEQSHardman & Co Research on Arbuthnot Banking Group (ARBB): 2023 - delivering strategy with strong profit growth
28th Mar 20247:00 amRNSAudited Final Results
21st Feb 20247:00 amRNSPre Close Trading Update
8th Feb 20241:57 pmRNSDirector/PDMR Shareholding
19th Dec 20232:06 pmRNSRenewal of Tier 2 Regulatory Capital Loan facility
5th Dec 202312:47 pmRNSDirector/PDMR Shareholding
13th Nov 20233:40 pmEQSHardman & Co Q&A on Arbuthnot Banking Group: Strategic progress and investments towards ‘Future State 2’
30th Oct 202310:34 amRNSDirector/PDMR Shareholding
26th Oct 202310:05 amRNSDirector/PDMR Shareholding
24th Oct 20233:15 pmEQSHardman & Co Research on Arbuthnot Banking Group (ARBB) Trading update: taking ABG to the next level
19th Oct 20237:00 amRNSThird Quarter 2023 Trading Update
22nd Aug 20237:00 amRNSAppointment of New Directors
4th Aug 202311:15 amEQSHardman & Co Research on Arbuthnot Banking Group (ARBB) 1H’23: steering through the interest rate wave
18th Jul 20237:00 amRNSUnaudited results for the 6 months to 30 June 2023
31st May 202312:37 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSTotal Voting Rights
24th May 20233:23 pmRNSAnnual General Meeting Result - 2023
24th May 20237:00 amRNSAnnual General Meeting 2023 Trading Update
5th May 20233:27 pmRNSHolding(s) in Company
5th May 20238:05 amRNSDirector/PDMR Shareholding
4th May 202311:32 amRNSResult of General Meeting and Total Voting Rights
3rd May 20231:45 pmEQSHardman & Co Q&A on Arbuthnot Banking Group (ARBB): Core and new franchises growth in profits and loans
14th Apr 20235:30 pmRNSPlacing and Subscription raising £12.0 million
6th Apr 202312:15 pmEQSHardman & Co Research on Arbuthnot Banking Group (ARBB) 2022: profits and growth in core and new franchises

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.